OMNIAMED Logo
COMPANY
Overview
CEO Message
Leadership
Partners
CI
Contact Us
R&D
R&D Overview
Pipeline Overview
Tech 1
Tech 2
Tech 3
PR
Press Release
Publications
Intellectual Property
RECRUIT
Careers
HOME
CONTACT US
ENG
ENG
KOR
COMPANY
Overview
CEO Message
Leadership
Partners
CI
Contact Us
R&D
R&D Overview
Pipeline Overview
Tech 1
Tech 2
Tech 3
PR
Press Release
Publications
Intellectual Property
RECRUIT
Careers
R&D
OmniaMed Co., Ltd. opens up a new paradigm for
the development of treatments using Nitric Oxide functionality.
R&D Overview
Pipeline Overview
Tech1
Tech2
Tech3
Tech1
Primary cancer -> Migration through blood or lymph vessel -> Engraftment and growth of cancer cells on lymph node
Therefore, a strategy to kill cancer cells by delivering drugs to targets of lymph nodes is needed.
inhibit cancer metastasis by delivering NO donors to lymph nodes
Tech 1 is a technology that suppresses cancer metastasis by killing cancer cells by delivering and supplying NO to lymph nodes.